Accordingly, targeting WEE1 can be an efficient approach to sensitize tumor cells to DNA-damaging agents [50], [51], particularly in TP53-mutated cells, based on the concept of synthetic lethality [52]. This evidence concerns the gene TP53 and neoplasm.